AKL RESEARCH & DEVELOPMENT LIMITED

Active Manchester

Research and experimental development on biotechnology

5 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
A

AKL RESEARCH & DEVELOPMENT LIMITED

Research and experimental development on biotechnology

Founded 20 Sept 2013 Active Manchester, England 5 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 23 Oct 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 16 Dec 2025 Next due 18 Dec 2026 8 months remaining
Net assets £2M £1M 2024 year on year
Total assets £2M £1M 2024 year on year
Total Liabilities £24K £51K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

The Lexicon Second Floor Mount Street Manchester M2 5NT England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for AKL RESEARCH & DEVELOPMENT LIMITED (08699350), an active life sciences and medical technology company based in Manchester, England. Incorporated 20 Sept 2013. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£1.29M

Decreased by £890.15k (-41%)

Net Assets

£1.58M

Decreased by £1.41M (-47%)

Total Liabilities

£24.13k

Decreased by £50.99k (-68%)

Turnover

N/A

Employees

5

Debt Ratio

2%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 1

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

9 Allotments 108,982 Shares £308287.65m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
22 Dec 20252,397£180k£75
20 Nov 202514,692£1.10m£75
22 Oct 20256,023£867k£144
27 Dec 202342,098£255202.79m£6.06m
16 Oct 20232,083£624.80m£300k

Officers

Officers

3 active
Status
Alan Vaughan ReynoldsDirectorBritishEngland7827 Feb 2018Active
David Richard SharplesDirectorBritishEngland7120 Sept 2013Active
David Richard SharplesSecretaryUnknownUnknown20 Sept 2013Active

Shareholders

Shareholders (96)

Dr Nicholas Larkins
15.6%
61,675
David Richard Sharples
12.7%
50,010

Persons with Significant Control

Persons with Significant Control (3)

3 Active

Nicholas Joihn Larkins

Australian

Active
Notified 12 May 2016
Residence Australia
DOB July 1947
Nature of Control
  • Significant Influence Or Control

David Keith Miles

British

Active
Notified 12 May 2016
Residence England
DOB July 1955
Nature of Control
  • Significant Influence Or Control

David Richard Sharples

British

Active
Notified 10 Sept 2016
Residence England
DOB April 1955
Nature of Control
  • Significant Influence Or Control

Group Structure

Group Structure

AKL RESEARCH & DEVELOPMENT LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
21 Jan 2026CapitalAllotment of shares (GBP 396,698) on 2025-12-22
16 Dec 2025Confirmation StatementConfirmation statement made on 2025-12-04 with updates
15 Dec 2025CapitalAllotment of shares (GBP 394,301) on 2025-11-20
2 Nov 2025CapitalAllotment of shares (GBP 379,609) on 2025-10-22
2 Nov 2025Persons With Significant ControlChange to Mr David Richard Sharples as a person with significant control on 2025-11-02
21 Jan 2026 Capital

Allotment of shares (GBP 396,698) on 2025-12-22

16 Dec 2025 Confirmation Statement

Confirmation statement made on 2025-12-04 with updates

15 Dec 2025 Capital

Allotment of shares (GBP 394,301) on 2025-11-20

2 Nov 2025 Capital

Allotment of shares (GBP 379,609) on 2025-10-22

2 Nov 2025 Persons With Significant Control

Change to Mr David Richard Sharples as a person with significant control on 2025-11-02

Recent Activity

Latest Activity

Allotment of shares (GBP 396,698) on 2025-12-22

3 months ago on 21 Jan 2026

Confirmation statement made on 2025-12-04 with updates

4 months ago on 16 Dec 2025

Allotment of shares (GBP 394,301) on 2025-11-20

4 months ago on 15 Dec 2025

Allotment of shares (GBP 379,609) on 2025-10-22

5 months ago on 2 Nov 2025

Change to Mr David Richard Sharples as a person with significant control on 2025-11-02

5 months ago on 2 Nov 2025